Checkpoint Trends Share Price Today | Stock Price & Checkpoint Trends Share Screener
As of May 18, 2026, the live Checkpoint Trends share price (BSE: CHECKPOINT) is ₹41.69, down 4.31% from the previous close, with shares trading between ₹41.45 and ₹45.00 in today's trading session, and a 52-week range of ₹39.28–₹138.75. Check CHECKPOINT 52-week performance for the annual price range and momentum. Use the Checkpoint Trends stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Checkpoint Trends opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹295 and net income of ₹2, with EBITDA of ₹3, an operating margin of 8.0% and a profit margin of 0.7%.
Checkpoint Trends Share Price Chart
Track the current stock price of Checkpoint Trends with an interactive chart. Analyse CHECKPOINT share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Checkpoint Trends stock quote in one place.
The quote of ₹41.69 sits between the 52-week low of ₹39.28 and the 52-week high of ₹138.75, and the latest session moved -4.31% from the previous close.
Checkpoint Trends Company Profile - Fundamental Screener
Screen Checkpoint Trends company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CHECKPOINT shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE396H01019.
Company Details
Classification
Identifiers and Leadership
Checkpoint Trends Balance Sheet Screener
Screen CHECKPOINT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹1, down from ₹1 in 2024.
Latest statistics put total assets at ₹1 and shareholder funds at ₹1.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Current Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 |
Checkpoint Trends Income Statement Screener - Profit & Revenue Analysis
Screen Checkpoint Trends income statement and profit fundamentals. Analyze CHECKPOINT quarterly results. Checkpoint Trends reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹295 and net profit was ₹2, equal to earnings per unit of ₹3.80, at an operating margin of 8%.
In that period expenses were ₹292, interest cost ₹0 and tax ₹1. The next period listed, 2025-March, shows revenue of ₹1 and net profit of ₹0.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 295 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 0 | 0 | 0 |
| Expenses | 292 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 0 | 0 | 0 |
Operating Costs and Margins | ||||||||||||
| EBITDA | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 8.00% | 11.00% | 3.00% | -7.00% | -1.00% | 2.00% | 2.00% | -31.00% | -2.00% | 10.00% | -3.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 |
| Tax | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 |
| EPS | 3.80 | 0.05 | 0.06 | -0.14 | -0.07 | 0.01 | 0.06 | -0.02 | -0.30 | 0.06 | -0.01 | -5.62 |
Checkpoint Trends Cash Flow Screener - Liquidity Fundamentals
Screen CHECKPOINT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹0.
Over the same period, investing activities provided ₹0 and financing activities provided ₹0.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 |
Checkpoint Trends Shareholding Pattern Screener
See Checkpoint Trends shareholding pattern with promoter, FII, and DII holdings. Check Checkpoint Trends promoter holding and ownership changes for CHECKPOINT on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 0.00%, foreign institutions 8.59%, domestic institutions 0.00% and the public 77.08%, spread across 2,457 shareholders.
The shareholder count was 2,457 in 2026-Mar, compared with 2,204 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Institutional Investors | ||||||||
| FII Holding | 8.59% | 10.85% | 10.86% | 10.86% | 10.71% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 77.08% | 71.77% | 70.20% | 73.69% | 75.24% | 90.38% | 91.05% | 88.12% |
| Other Holding | 14.32% | 17.37% | 18.94% | 15.46% | 14.05% | 9.62% | 8.95% | 11.88% |
| Shareholder Count | 2,457 | 2,204 | 2,277 | 2,416 | 2,396 | 1,981 | 2,039 | 2,073 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Checkpoint Trends. Checkpoint Trends dividend yield can be compared with peers and other stocks in the market.
Checkpoint Trends Stock Index Membership - Nifty & Sensex
See which indices include Checkpoint Trends stock. Check CHECKPOINT index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Checkpoint Trends Market Events Screener - Corporate Actions
Get Checkpoint Trends corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Checkpoint Trends stock events that may affect CHECKPOINT share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Quarterly Result Announcement dated January 28, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 42.77% | ||
| Annual General Meeting | NA | 34.42% | ||
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -3.99% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 10.36% |
| 2025-10-27 | 2025-10-27 | Extraordinary General Meeting | NA | 21.67% |
| 2025-10-13 | 2025-10-13 | Extraordinary General Meeting | NA | 42.32% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | 8.10% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -11.59% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 36.16% |
| 2025-02-12 | 2025-02-12 | Extraordinary General Meeting | NA | 10.86% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 3.93% |
| 2023-02-10 | 2023-02-10 | Change Of Name | NA | - |
Checkpoint Trends Competitors Screener - Peer Stocks Comparison
Screen CHECKPOINT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Checkpoint Trends Company Announcements - News & Reports Screener
Screen CHECKPOINT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated April 29, 2026.
The next most recent announcements are dated April 29, 2026 and April 24, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-04-29 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-29 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-24 | Clarification On Price Movement Of Equity Shares | - |
| 2026-04-15 | Clarification Sought from Checkpoint Trends Ltd | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-18 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-03-10 | Board Meeting Intimation for The Meeting Of Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday March 18 2026 | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-03-05 | Board Meeting Outcome for Subject: Outcome Of The Board Meeting For Allotment Of 16674072 (One Crores Sixty Six Lakhs Seventy Four Thousand Seventy Two) Convertible Warrants (Warrants). | - |
| 2026-02-25 | Cancellation Of Board Meeting | - |
| 2026-02-20 | Board Meeting Intimation for Intimation Of Board Meeting For The Meeting To Be Held On February 25 2026 | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-02 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-02-02 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-28 | Second Corrigendum To The Notice Of Extra Ordinary General Meeting | - |
| 2026-01-28 | Unaudited Result For The Quarter Ended December 31 2025 | - |
| 2026-01-19 | Board Meeting Intimation for Intimation Of Board Meeting | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹41.69, within a 52-week range of ₹39.28 to ₹138.75. The P/E ratio is 12.22 and the P/B ratio is 12.69, with earnings per unit of ₹0.05. Market capitalisation stands at ₹23.75 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on May 24, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.